Enhancement of homocysteine toxicity to insulin-secreting BRIN-BD11 cells in combination with alloxan

S. M. J. Scullion, E. Gurgul-Convey, M. Elsner, S. Lenzen, Peter Flatt, Neville McClenaghan

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Previous studies have shown that homocysteine (HC) has a detrimental impact on insulin secretion and pancreatic beta cell function. The aim of the present study was to determine the role of reactive oxygen species (ROS) in the in vitro toxic effects of HC on insulin secretion and function of BRIN-BD11 insulin-secreting cells. In this study, insulin secretion from BRIN-BD11 cells was determined radioimmunologically, cell viability by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay and glucokinase activity by a glucose phosphorylation assay following culture with HC plus alloxan (Alx). Treatment with HC resulted in concentration-dependent inhibition of insulin secretion induced by glucose and other insulinotropic agents. HC in combination with Alx resulted in a more pronounced decline in insulin secretion, including that induced by 20 mM alanine, by 43% (P<0.001) and 30 mM KCl by 60% (P<0.001), compared with control culture. The glucokinase phosphorylating capacity in cells cultured with HC plus Alx was significantly lower, compared with control cells. The cells also displayed a significant 84% (P<0.001) decline in cell viability. Prolonged, 72-h culture of insulin-secreting cells with HC followed by 18-h culture without HC did not result in full restoration of beta cell responses to insulinotropic agents. In vitro oxygen consumption was enhanced by a combination of Alx with HC. The study arrived at the conclusion that HC generates ROS in a redox-cycling reaction with Alx that explains the decline in viability of insulin-secreting cells, leading to reduced glucokinase phosphorylating ability, diminished insulin secretory responsiveness and cell death. Journal of Endocrinology (2012) 214, 233-238
LanguageEnglish
Pages233-238
JournalJournal of Endrocrinology
Volume214
Issue number2
DOIs
Publication statusPublished - Aug 2012

Fingerprint

Alloxan
Homocysteine
Insulin
Insulin-Secreting Cells
Glucokinase
Reactive Oxygen Species
Cell Survival
Glucose
Endocrinology
Poisons
Oxygen Consumption
Alanine
Oxidation-Reduction
Cultured Cells
Cell Death
Phosphorylation

Cite this

Scullion, S. M. J. ; Gurgul-Convey, E. ; Elsner, M. ; Lenzen, S. ; Flatt, Peter ; McClenaghan, Neville. / Enhancement of homocysteine toxicity to insulin-secreting BRIN-BD11 cells in combination with alloxan. In: Journal of Endrocrinology. 2012 ; Vol. 214, No. 2. pp. 233-238.
@article{56a01ede0f154ffdbfb0f50c98ad2001,
title = "Enhancement of homocysteine toxicity to insulin-secreting BRIN-BD11 cells in combination with alloxan",
abstract = "Previous studies have shown that homocysteine (HC) has a detrimental impact on insulin secretion and pancreatic beta cell function. The aim of the present study was to determine the role of reactive oxygen species (ROS) in the in vitro toxic effects of HC on insulin secretion and function of BRIN-BD11 insulin-secreting cells. In this study, insulin secretion from BRIN-BD11 cells was determined radioimmunologically, cell viability by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay and glucokinase activity by a glucose phosphorylation assay following culture with HC plus alloxan (Alx). Treatment with HC resulted in concentration-dependent inhibition of insulin secretion induced by glucose and other insulinotropic agents. HC in combination with Alx resulted in a more pronounced decline in insulin secretion, including that induced by 20 mM alanine, by 43{\%} (P<0.001) and 30 mM KCl by 60{\%} (P<0.001), compared with control culture. The glucokinase phosphorylating capacity in cells cultured with HC plus Alx was significantly lower, compared with control cells. The cells also displayed a significant 84{\%} (P<0.001) decline in cell viability. Prolonged, 72-h culture of insulin-secreting cells with HC followed by 18-h culture without HC did not result in full restoration of beta cell responses to insulinotropic agents. In vitro oxygen consumption was enhanced by a combination of Alx with HC. The study arrived at the conclusion that HC generates ROS in a redox-cycling reaction with Alx that explains the decline in viability of insulin-secreting cells, leading to reduced glucokinase phosphorylating ability, diminished insulin secretory responsiveness and cell death. Journal of Endocrinology (2012) 214, 233-238",
author = "Scullion, {S. M. J.} and E. Gurgul-Convey and M. Elsner and S. Lenzen and Peter Flatt and Neville McClenaghan",
year = "2012",
month = "8",
doi = "10.1530/JOE-11-0461",
language = "English",
volume = "214",
pages = "233--238",
journal = "Journal of Endrocrinology",
issn = "0022-0795",
number = "2",

}

Enhancement of homocysteine toxicity to insulin-secreting BRIN-BD11 cells in combination with alloxan. / Scullion, S. M. J.; Gurgul-Convey, E.; Elsner, M.; Lenzen, S.; Flatt, Peter; McClenaghan, Neville.

In: Journal of Endrocrinology, Vol. 214, No. 2, 08.2012, p. 233-238.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Enhancement of homocysteine toxicity to insulin-secreting BRIN-BD11 cells in combination with alloxan

AU - Scullion, S. M. J.

AU - Gurgul-Convey, E.

AU - Elsner, M.

AU - Lenzen, S.

AU - Flatt, Peter

AU - McClenaghan, Neville

PY - 2012/8

Y1 - 2012/8

N2 - Previous studies have shown that homocysteine (HC) has a detrimental impact on insulin secretion and pancreatic beta cell function. The aim of the present study was to determine the role of reactive oxygen species (ROS) in the in vitro toxic effects of HC on insulin secretion and function of BRIN-BD11 insulin-secreting cells. In this study, insulin secretion from BRIN-BD11 cells was determined radioimmunologically, cell viability by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay and glucokinase activity by a glucose phosphorylation assay following culture with HC plus alloxan (Alx). Treatment with HC resulted in concentration-dependent inhibition of insulin secretion induced by glucose and other insulinotropic agents. HC in combination with Alx resulted in a more pronounced decline in insulin secretion, including that induced by 20 mM alanine, by 43% (P<0.001) and 30 mM KCl by 60% (P<0.001), compared with control culture. The glucokinase phosphorylating capacity in cells cultured with HC plus Alx was significantly lower, compared with control cells. The cells also displayed a significant 84% (P<0.001) decline in cell viability. Prolonged, 72-h culture of insulin-secreting cells with HC followed by 18-h culture without HC did not result in full restoration of beta cell responses to insulinotropic agents. In vitro oxygen consumption was enhanced by a combination of Alx with HC. The study arrived at the conclusion that HC generates ROS in a redox-cycling reaction with Alx that explains the decline in viability of insulin-secreting cells, leading to reduced glucokinase phosphorylating ability, diminished insulin secretory responsiveness and cell death. Journal of Endocrinology (2012) 214, 233-238

AB - Previous studies have shown that homocysteine (HC) has a detrimental impact on insulin secretion and pancreatic beta cell function. The aim of the present study was to determine the role of reactive oxygen species (ROS) in the in vitro toxic effects of HC on insulin secretion and function of BRIN-BD11 insulin-secreting cells. In this study, insulin secretion from BRIN-BD11 cells was determined radioimmunologically, cell viability by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay and glucokinase activity by a glucose phosphorylation assay following culture with HC plus alloxan (Alx). Treatment with HC resulted in concentration-dependent inhibition of insulin secretion induced by glucose and other insulinotropic agents. HC in combination with Alx resulted in a more pronounced decline in insulin secretion, including that induced by 20 mM alanine, by 43% (P<0.001) and 30 mM KCl by 60% (P<0.001), compared with control culture. The glucokinase phosphorylating capacity in cells cultured with HC plus Alx was significantly lower, compared with control cells. The cells also displayed a significant 84% (P<0.001) decline in cell viability. Prolonged, 72-h culture of insulin-secreting cells with HC followed by 18-h culture without HC did not result in full restoration of beta cell responses to insulinotropic agents. In vitro oxygen consumption was enhanced by a combination of Alx with HC. The study arrived at the conclusion that HC generates ROS in a redox-cycling reaction with Alx that explains the decline in viability of insulin-secreting cells, leading to reduced glucokinase phosphorylating ability, diminished insulin secretory responsiveness and cell death. Journal of Endocrinology (2012) 214, 233-238

U2 - 10.1530/JOE-11-0461

DO - 10.1530/JOE-11-0461

M3 - Article

VL - 214

SP - 233

EP - 238

JO - Journal of Endrocrinology

T2 - Journal of Endrocrinology

JF - Journal of Endrocrinology

SN - 0022-0795

IS - 2

ER -